Metastatic Colorectal Cancer
Metastatic colorectal cancer (mCRC) is an advanced stage of colorectal cancer where the cancer has spread beyond the colon or rectum to other parts of the body, often leading to serious health complications.
We are studying whether tinzaparin can help prevent blood clots in patients with metastatic colorectal cancer starting their first line of treatment. This may help reduce the risk of complications related to blood clots.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic colorectal cancer (mCRC) is an advanced stage of colorectal cancer where the cancer has spread beyond the colon or rectum to other parts of the body, often leading to serious health complications.
A thromboembolic event occurs when a blood clot forms in a blood vessel and travels to another part of the body, potentially causing serious complications such as a stroke or pulmonary embolism.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.